Diagnosis and therapy of chromoblastomycosis

Authors

  • Nita Damayanti Universitas Gadjah Mada image/svg+xml
  • Laily N Qomariah Wates Hospital , Daerah Istimewa Yogyakarta, Indonesia
  • Hari Purwanto Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia
  • Agnes S Siswati Department of Dermatology and Venereology, Faculty of Medicine, Public Health, and Nursing, Universitas Gadjah Mada, Yogyakarta, Indonesia Gedung Radiopoetro lantai 3, Jl. Farmako Sekip Utara, Senolowo, Sinduadi, Kec. Mlati, Kabupaten Sleman, Daerah Istimewa Yogyakarta 55281, Indonesia

DOI:

https://doi.org/10.66344/jpad.v32i2.1901

Abstract

Chromoblastomycosis is a chronic deep mycosis of the skin and subcutaneous tissue. Clinical features are characterized by verrucous plaque lesions, especially in the lower extremities. The disease is difficult to cure and there is no gold standard therapy. A 72-year-old male farmer comes with thickened and bleeding skin on the left leg. For 10 years the thickened skin extends slowly from the back of the foot to the length of the left leg down to the bottom of the knee. A month earlier, the thickened skin becomes brittle and bleeding with hyperkeratotic plaques, verrucosa, multiple partial exudative, and hemorrhagic fissures. Scrapping skin lesions with 10% potassium hydroxide showing muriform cell (sclerotic bodies). Histopathological examination of granuloma inflammation composed of foamy macrophages, lymphocytes, histiocytes, multinucleated giant cells and many neutrophils, erythrocyte extravasation, and sclerotic bodies obtained in the brown dermis. Culture on Sabouraud dextrose agar media with chloramphenicol did not fungal colony growth. Patients have been treated with itraconazole 200 mg twice daily and showed clinical improvement after 3 weeks.  Diagnosis of chromoblastomycosis is based on history, physical examination, histopathology, and culture. The risk factors for the disease include farmers who work barefoot. Further evaluation is still needed regarding the therapy and complications in this case. 

References

1. Hay RJ. Deep Fungal Infection. In: Wolff K, Goldsmith LA, Katz SI, Gilchrest BA, Paller AS, Leffell DJ, editor. Fitzpatrick's Dermatology in General Medicine. 8th edition. New York: The McGraw-Hill Companies; 2011. p. 2315-6.

2. Hay RJ, RCP. Fungal infections. Clin Dermatol. 2006;24:201-12.

3. Baddley JW and Dismukes WE. Chromoblastomycosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essential of Clinical Mycology. 2nd edition. New York: Springer Science-Business Media; 2011. p. 427-31.

4. Rivitti EA, Aoki V. Deep Fungal Infections in Tropical Countries. Clin Dermatol. 1999;17:171-90.

5. Lupi O, Trying SK, McGinnis MR. Tropical dermatology: tropical fungal diseases. J Am Acad Dermatol. 2005;53(6):938-9.

6. Hay RJ and Ashbee HR. Mycology. In: Burns T, Breathnach S, Cox N, Griffiths C, editors. Rook's Textbook of Dermatology. 8th edition. Oxford United Kingdom: Blackwell Publishing; 2010. p. 36.75-6.

7. T. Matsumoto Chromoblastomycosis and phaeohyphomycosis. In: Guerrant RL, Walker DH, and Weller PF. Tropical Infectious Diseases. 2nd edition. Philadelphia: Elsevier; 2006. p. 898-902.

8. Richardson MD, Warnock DW. Fungal Infection, Diagnosis and Management. 3rd ed. Oxford United Kingdom: Blackwell Publishing; 2003. p. 288-92.

9. Queiroz-Telles F, McGinnis MR, Salkin I, Graybill JR. Subcutaneous mycoses. Infect Dis Clin North Am. 2003;17:59-85.

10. Prasetyo AD and Suyoso S. A retrospective study: subcutaneous mycoses in Inpatient Health Dermatology Hospital Dr. Soetomo Years 2000-2009 (a period of 10 years). Surabaya: Periodic Health Sciences Dermatology. 2011;23(1):17-24.

11. Esterre P and Queiroz-Telles F. Management of chromoblastomycosis: novel perspectives. Curr Opin Infect Dis. 2006;19:148-52.

12. CB Doherty, Doherty SD, Rosen T. thermotherapy in dermatologic infections. J Am Acad Dermatol. 2010;62:917-8.

13. Ameen M. Chromoblastomycosis: clinical presentation and management. Dermatol Clin Exper. 2009;34:849-54.

14. James WD, Elston DM, Berger TG. Andrews' Diseases of the Skin Clinical Dermatology. 11th edition. Philadelphia: Elsevier Inc; 2011. p.313-4

15. PradhanSV, Taiwar OP, Ghosh A, Swami RM, KC Shiva Raj, S. Gupta Chromoblatomycosis in Nepal: A Study of 13 cases. Indian J Dermatoly, Venerol, Leprol. 2007;73:176-8.

16. Silva JP, De Souza W, Rozental S. Chromoblastomycosis: a retrospective study of 325 cases on Amazonic Region (Brazil). Mycopathologia. 1998;143:171-5.

17. Minotto R, Bernardi CDV, Mallmann LF, Edelweiss MIA, Scroferneker ML, Chromoblastomycosis: A review of 100 cases in the state of Rio Grande do Sul, Brazil. J Am Acad Dermatol. 2001;44:585-92.

Downloads

Published

01.06.2022

Issue

Section

Case Reports

How to Cite

1.
Diagnosis and therapy of chromoblastomycosis. J Pak Assoc Dermatol [Internet]. 2022 Jun. 1 [cited 2026 Aug. 15];32(2):443-8. Available from: https://www.jpad.com.pk/index.php/jpad/article/view/1901